Vir Biotechnology, Inc.
VIR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -80.2% | -60% | -75.5% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -63,005% | -7,932.9% | -3,779.1% | -617.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -66,656.3% | -9,528.2% | -4,474.3% | -810% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -67,975.4% | -9,139.9% | -3,989.6% | -845.2% |
| EPS Diluted | -1.17 | -0.8 | -0.88 | -0.76 |
| % Growth | -46.2% | 9.1% | -15.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |